NK cell activity is inhibited in patients with acute myeloid leukemia (AML) [50]; this observation was correlated to the presence of transforming growth factor (TGF)-β in microvesiclesfrom the serum of AML patients [51]. Here, TGFB1 is linked to acute myeloid leukemia.